The aim of the study was to compare the levels of the selected non-standard parameters in the CSF (GFAP, NF-H, S100B, UCHCL1) in patients with MS in the group of VitD deficiency with the group with normal VitD levels. The gene discussed is NEFH; the disease is myeloid sarcoma.